Sushruta Surgicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 13-12-2024
- Paid Up Capital ₹ 1.20 M
as on 13-12-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.90 M
as on 13-12-2024
- Revenue 145.60%
(FY 2022)
- Profit 613.20%
(FY 2022)
- Ebitda -42.20%
(FY 2022)
- Net Worth 83.17%
(FY 2022)
- Total Assets 68.64%
(FY 2022)
About Sushruta Surgicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹9.90 M.
Gopal Agrawal and Mukesh Agrawal serve as directors at the Company.
- CIN/LLPIN
U74999OR2016PTC025808
- Company No.
025808
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sushruta Surgicals Private Limited offer?
Sushruta Surgicals Private Limited offers a wide range of products and services, including Carts, Dollies & Trolleys, Cylinder Trolley, Forceps & Graspers, Endoscopic Accessories, Laparoscopic Instruments, Diagnostic Medical Imaging Equipment, Doppler Machine, Hospital and Medical Furniture, Hospital Bed and Mattress, Surgical & ICU Equipments.
Who are the key members and board of directors at Sushruta Surgicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Agrawal  | Director | 16-Sep-2016 | Current |
| Mukesh Agrawal | Director | 16-Sep-2016 | Current |
Financial Performance of Sushruta Surgicals.
Sushruta Surgicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 145.6% increase. The company also saw a substantial improvement in profitability, with a 613.2% increase in profit. The company's net worth Soared by an impressive increase of 83.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sushruta Surgicals?
Unlock access to Sushruta Surgicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 23 Oct 2018 | ₹9.90 M | Open |
How Many Employees Work at Sushruta Surgicals?
Sushruta Surgicals has a workforce of 10 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sushruta Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sushruta Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
